Increasing Access to Breast Cancer Screening Among Immigrants

Not Applicable

Active, not recruiting

• Conditions: Cancer Screening
• Interventions: Other: Mother tongue and Norwegian

• Registration Number: NCT04672265
• Lead Sponsor: Oslo University Hospital

Brief Summary

The investigators aim to test whether inviting immigrants to breast cancer screening with a letter in their mother tongue in addition to the standard letter in Norwegian changes screening uptake in these immigrant groups, compared with a comparable group who receive the invitation in Norwegian only,

Detailed Description

Women in selected immigrant groups according to birth country will be invited to screening and randomized in a 1:1 ratio to receive the screening invitation and information material 1) in the major official native language in the country the invitee is born in addition to Norwegian (intervention group), or 2) only Norwegian (control). The 13 selected countries of origin are Poland, the Philippines, Pakistan, Somalia and Arabic speaking countries (Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia). The five intervention languages will thus be Polish, English, Urdu, Somali and Arabic.

Study Timeline

• Study First Submitted: 2020-11-16
• Study First Submitted QC: 2020-12-16
• Study First Posted: 2020-12-17
• Study Start: 2021-04-15
• Primary Completion: 2022-08-31
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-02
• Last Update Posted: 2024-04-03
• Study Completion: 2030-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 11355

Inclusion Criteria

• Invited to screening program during the study recruitment period (January 2021-June 2022)
• The registered country of birth of the invitee is one of the following; Poland, Pakistan, Philippines, Somalia, Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia

Exclusion Criteria

• Not reached with the screening invitation letter because of wrong address or similar

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Mother tongue and Norwegian	Mother tongue and Norwegian	Written material related to screening sent to the invitee in two languages.

Primary Outcome Measures

Name	Time	Method
Screening attendance	0-6 months after sent screening invitation letter	Attendance in breast cancer screening programme (yes/no)

Trial Locations

Locations (1)

Oslo University Hospital, Cancer Registry; 🇳🇴 Oslo, Norway